PC
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| The analysis of GSTA1 promoter genetic and functional diversity of human populations | Scientific reports |  | 2021 | 277 | 209 | ||
| Genetic Susceptibility to Hepatic Sinusoidal Obstruction Syndrome in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation |  | 2020 | 338 | 0 | ||
| Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation | British Journal of Clinical Pharmacology | | 2018 | 371 | 146 | ||
| Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation | The Pharmacogenomics Journal | | 2018 | 522 | 225 | ||
| Development and validation of an allele-specific PCR assay for genotyping a promoter and exonic single nucleotide polymorphisms of MGMT gene | Journal of Biological Methods | | 2018 | 317 | 148 | ||
| GSTA1 Genetic Variants and Conditioning Regimen: Missing Key Factors in Dosing Guidelines of Busulfan in Pediatric Hematopoietic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation | | 2017 | 490 | 17 | ||
| GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study | Oncotarget | | 2017 | 551 | 242 | ||
| Potential Predictive Biomarkers used to optimize treatments for Sinusoidal Obstruction Syndrome in pediatric Hematopoietic stem cell transplantation | Bulletin suisse du cancer | | 2016 | 448 | 1,779 | ||
| Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use | International Journal of Molecular Sciences | | 2016 | 581 | 428 | ||
| Creation of the Swiss group of pharmacogenomics and personalized therapy (SPT) | Paediatrica | | 2016 | 375 | 82 |
